| Literature DB >> 30011084 |
David J Olivos1,2,3, Daniel S Perrien4,5, Adam Hooker2, Ying-Hua Cheng2, Robyn K Fuchs6, Jung Min Hong7, Angela Bruzzaniti7, Kristin Chun8, Christine M Eischen9, Melissa A Kacena2, Lindsey D Mayo3,8.
Abstract
Mouse double minute 2 (Mdm2) is a multifaceted oncoprotein that is highly regulated with distinct domains capable of cellular transformation. Loss of Mdm2 is embryonically lethal, making it difficult to study in a mouse model without additional genetic alterations. Global overexpression through increased Mdm2 gene copy number (Mdm2Tg ) results in the development of hematopoietic neoplasms and sarcomas in adult animals. In these mice, we found an increase in osteoblastogenesis, differentiation, and a high bone mass phenotype. Since it was difficult to discern the cell lineage that generated this phenotype, we generated osteoblast-specific Mdm2 overexpressing (Mdm2TgOb ) mice in 2 different strains, C57BL/6 and DBA. These mice did not develop malignancies; however, these animals and the MG63 human osteosarcoma cell line with high levels of Mdm2 showed an increase in bone mineralization. Importantly, overexpression of Mdm2 corrected age-related bone loss in mice, providing a role for the proto-oncogenic activity of Mdm2 in bone health of adult animals.Entities:
Keywords: bone mass; mouse double minute 2 (Mdm2); osteoblast (OB)
Mesh:
Substances:
Year: 2018 PMID: 30011084 PMCID: PMC6348883 DOI: 10.1002/jcb.27133
Source DB: PubMed Journal: J Cell Biochem ISSN: 0730-2312 Impact factor: 4.429